Kirk Randal J (CIK 0001091823)

Latest company ownership

PGEN - PRECIGEN, INC.
Role: Director
Shares held
118,391,976
Last filed at
Nov 21, 2025
Confidence Score
3.2
2025Q4
Confidence Score History
2015Q1 2025Q4
Shares held
8,675,768
Last filed at
Dec 19, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q4 2025Q4
OGEN - ORAGENICS INC
Role: 10% Owner
Shares held
1,000,555
Last filed at
Dec 26, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q3 2025Q4
Shares held
152,425
Last filed at
Nov 24, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
102,043
Last filed at
Sep 2, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2011Q1 2025Q4
PRPO - Precipio, Inc.
Role: 10% Owner
Shares held
27,151
Last filed at
Aug 30, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2011Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 22, 2025 Dec 22, 2025 PRECIGEN, INC. Director Sell 16.3 -1,900,036 -1.53% ✗ $7.9M
Nov 19, 2025 Nov 21, 2025 PRECIGEN, INC. Director Sell 15.0 -2,966,293 -2.34% ✗ $12.3M
Sep 30, 2025 Sep 30, 2025 PRECIGEN, INC. Director Sell 16.3 -1,809,667 -1.41% ✗ $6.2M
Sep 17, 2025 Sep 19, 2025 PRECIGEN, INC. Director Sell 15.0 -5,000,252 -9.70% ✗ $18.7M
Aug 9, 2024 Aug 13, 2024 PRECIGEN, INC. Director Buy 100.0 +23,529,411 25.42% ✗ $20M
Dec 28, 2023 Dec 29, 2023 PRECIGEN, INC. Director Buy 60.0 +96,686 0.10% ✗ $136.3K
Aug 15, 2023 Aug 17, 2023 PRECIGEN, INC. Director Buy 75.0 +500,000 0.57% ✗ $757.6K
Jan 27, 2023 Jan 31, 2023 PRECIGEN, INC. Director Buy 100.0 +11,428,571 13.52% ✗ $20M
Nov 23, 2021 Nov 24, 2021 AQUABOUNTY TECHNOLOGIES INC 10% Owner Sell 15.0 -12,880,000 -70.69% ✗ $27M
Nov 19, 2021 Nov 23, 2021 PRECIGEN, INC. Director Buy 87.5 +1,000,000 1.59% ✗ $3.6M
Aug 11, 2020 Aug 13, 2020 PRECIGEN, INC. Chair Buy 93.8 +1,209,384 4.57% ✗ $5.3M
Aug 11, 2020 Aug 13, 2020 AQUABOUNTY TECHNOLOGIES INC 10% Owner Buy 100.0 +4,000,000 28.06% ✗ $10M
Mar 19, 2020 Mar 20, 2020 PRECIGEN, INC. Chair Buy 87.5 +1,000,000 1.23% ✗ $2.2M
Feb 13, 2020 Feb 18, 2020 AQUABOUNTY TECHNOLOGIES INC 10% Owner Buy 100.0 +5,175,000 57.01% ✗ $7.8M
Jan 31, 2020 Feb 4, 2020 PRECIGEN, INC. Chair Buy 97.5 +6,005,919 7.95% ✗ $35M
Dec 13, 2019 Dec 17, 2019 PRECIGEN, INC. 10% Owner Sell 36.3 -1,946,278 -100.00% ✗ $5.8M
Jun 6, 2019 Jun 10, 2019 PRECIGEN, INC. CEO Buy 77.5 +322,179 0.64% ✗ $1.7M
Jun 6, 2019 Jun 10, 2019 PRECIGEN, INC. CEO Buy 87.5 +483,268 2.06% ✗ $2.5M
May 31, 2019 Jun 4, 2019 PRECIGEN, INC. CEO Buy 67.5 +135,548 0.28% ✗ $665.5K
May 31, 2019 Jun 4, 2019 PRECIGEN, INC. CEO Buy 85.0 +432,493 1.71% ✗ $998.3K
May 29, 2019 May 30, 2019 PRECIGEN, INC. CEO Buy 77.5 +330,180 0.67% ✗ $1.6M
May 29, 2019 May 30, 2019 PRECIGEN, INC. CEO Buy 87.5 +495,271 2.18% ✗ $2.4M
May 22, 2019 May 24, 2019 PRECIGEN, INC. CEO Buy 77.5 +273,367 0.56% ✗ $1.3M
May 22, 2019 May 24, 2019 PRECIGEN, INC. CEO Buy 87.5 +410,050 1.84% ✗ $1.9M
May 17, 2019 May 21, 2019 PRECIGEN, INC. CEO Buy 77.5 +422,423 0.87% ✗ $2M
May 17, 2019 May 21, 2019 PRECIGEN, INC. CEO Buy 92.5 +633,631 2.92% ✗ $2.9M
May 13, 2019 May 15, 2019 PRECIGEN, INC. CEO Buy 87.5 +838,482 1.75% ✗ $3.7M
May 13, 2019 May 15, 2019 PRECIGEN, INC. CEO Buy 96.3 +1,257,727 6.15% ✗ $5.5M
Apr 1, 2019 Apr 3, 2019 PRECIGEN, INC. 10% Owner Sell 22.5 -150,565 -39.81% ✗ $98.8K
Jan 11, 2019 Jan 15, 2019 PRECIGEN, INC. 10% Owner Sell 22.5 -998,204 -37.10% ✗ $158.8K
Aug 28, 2018 Aug 30, 2018 Precipio, Inc. 10% Owner Sell 26.3 -24,600 -1.81% ✗ $10.1K
Aug 24, 2018 Aug 28, 2018 HALOZYME THERAPEUTICS, INC. 10% Owner Sell 15.0 -644,998 -4.38% ✗ $11.7M
Aug 21, 2018 Aug 23, 2018 HALOZYME THERAPEUTICS, INC. 10% Owner Sell 15.0 -1,194,462 -7.50% ✗ $21.1M
Aug 14, 2018 Aug 16, 2018 HALOZYME THERAPEUTICS, INC. 10% Owner Sell 16.3 -490,072 -2.99% ✗ $8.5M
Aug 8, 2018 Aug 10, 2018 HALOZYME THERAPEUTICS, INC. 10% Owner Sell 16.3 -572,804 -3.37% ✗ $9.9M
Jul 25, 2018 Jul 27, 2018 HALOZYME THERAPEUTICS, INC. 10% Owner Sell 16.3 -302,827 -1.75% ✗ $5.2M
Jul 3, 2018 Jul 6, 2018 PRECIGEN, INC. CEO Buy 100.0 +7,479,431 12.61% ✗ $100M
Jun 27, 2018 Jun 29, 2018 HALOZYME THERAPEUTICS, INC. 10% Owner Sell 16.3 -304,321 -1.73% ✗ $5.2M
Jan 19, 2018 Jan 22, 2018 PRECIGEN, INC. CEO Buy 90.0 +1,000,000 1.73% ✗ $12.5M
Jan 17, 2018 Jan 19, 2018 PRECIGEN, INC. 10% Owner Buy 100.0 +1,538,461 25.64% ✗ $5M
Dec 11, 2017 Dec 13, 2017 PRECIGEN, INC. 10% Owner Buy 100.0 +2,727,273 49.23% ✗ $2.1M
Aug 11, 2017 Aug 14, 2017 PRECIGEN, INC. CEO Buy 70.0 +132,625 0.24% ✗ $2.5M
Jun 8, 2017 Jun 12, 2017 Precipio, Inc. 10% Owner Sell 17.5 -1,975,000 -26.16% ✗ $2M
May 4, 2017 May 8, 2017 PRECIGEN, INC. 10% Owner Sell 20.0 -160,968 -23.44% ✗ $501.9K
Jan 18, 2017 Jan 20, 2017 PRECIGEN, INC. 10% Owner Buy 100.0 +1,575,046 34.87% ✗ $25M
Dec 27, 2016 Dec 29, 2016 PRECIGEN, INC. 10% Owner Sell 22.5 -177,020 -11.15% ✗ $84.4K
Dec 13, 2016 Dec 14, 2016 PRECIGEN, INC. CEO Buy 65.0 +34,606 0.06% ✗ $1M
Jun 30, 2016 Jul 5, 2016 PRECIGEN, INC. 10% Owner Buy 100.0 +2,261,419 17.11% ✗ $1.2M
May 13, 2016 May 16, 2016 PRECIGEN, INC. CEO Buy 65.0 +41,830 0.07% ✗ $1M
Jan 6, 2016 Jan 11, 2016 Precipio, Inc. 10% Owner Buy 100.0 +4,474,825 145.48% ✗ $4.5M
Dec 11, 2015 Dec 14, 2015 PRECIGEN, INC. CEO Buy 70.0 +124,475 0.20% ✗ $3.7M
Dec 7, 2015 Dec 7, 2015 PRECIGEN, INC. CEO Buy 71.3 +237,525 0.38% ✗ $7.3M
Sep 2, 2015 Sep 4, 2015 PRECIGEN, INC. 10% Owner Buy 95.0 +937,500 7.62% ✗ $3M
Jul 27, 2015 Jul 27, 2015 PRECIGEN, INC. 10% Owner Buy 96.3 +975,987 6.24% ✗ $5.7M
Mar 16, 2015 Mar 18, 2015 PRECIGEN, INC. 10% Owner Buy 100.0 +13,939,392 31.68% ✗ $2.3M
Feb 9, 2015 Feb 10, 2015 PRECIGEN, INC. Director Buy 97.5 +1,440,000 8.08% ✗ $12.6M
Jan 27, 2015 Jan 27, 2015 PRECIGEN, INC. CEO Buy 80.0 +555,556 0.91% ✗ $15M
Dec 17, 2013 Dec 19, 2013 Theriva Biologics, Inc. 10% Owner Buy 100.0 +2,500,000 25.51% ✗ $2.5M
Nov 20, 2013 Nov 22, 2013 ORAGENICS INC 10% Owner Buy 100.0 +1,242,490 15.73% ✗ $3.1M
Oct 29, 2013 Oct 31, 2013 Alaunos Therapeutics, Inc. Director Buy 100.0 +2,857,143 19.12% ✗ $10M
Sep 30, 2013 Oct 2, 2013 ORAGENICS INC 10% Owner Buy 100.0 +2,648,510 50.45% ✗ $7.9M
Oct 29, 2012 Oct 31, 2012 Theriva Biologics, Inc. 10% Owner Buy 100.0 +3,125,000 46.81% ✗ $5M
Jul 31, 2012 Aug 2, 2012 ORAGENICS INC 10% Owner Buy 100.0 +857,555 19.52% ✗ $1.3M
Jun 1, 2012 Jun 5, 2012 HALOZYME THERAPEUTICS, INC. Director Buy 77.5 +194,189 0.98% ✗ $1.4M
May 15, 2012 May 17, 2012 HALOZYME THERAPEUTICS, INC. Director Buy 96.3 +1,071,498 5.74% ✗ $8M
Feb 10, 2012 Feb 13, 2012 HALOZYME THERAPEUTICS, INC. Director Buy 97.5 +1,360,000 7.87% ✗ $14.4M
Jan 20, 2012 Jan 23, 2012 Alaunos Therapeutics, Inc. Director Buy 100.0 +1,923,075 20.54% ✗ $10M
Nov 21, 2011 Nov 23, 2011 HALOZYME THERAPEUTICS, INC. Director Buy 87.5 +277,723 1.63% ✗ $2.2M
Nov 14, 2011 Nov 16, 2011 HALOZYME THERAPEUTICS, INC. Director Buy 93.8 +638,224 3.90% ✗ $5.2M
Nov 8, 2011 Nov 9, 2011 Precipio, Inc. 10% Owner Buy 97.5 +245,903 100.00% ✗ $300K
Aug 23, 2011 Aug 25, 2011 Alaunos Therapeutics, Inc. Director Buy 65.0 +38,294 0.41% ✗ $191.1K
Aug 18, 2011 Aug 22, 2011 Alaunos Therapeutics, Inc. Director Buy 95.0 +461,646 5.22% ✗ $2.3M
Aug 9, 2011 Aug 11, 2011 HALOZYME THERAPEUTICS, INC. Director Buy 96.3 +1,000,000 6.51% ✗ $5.9M
Aug 5, 2011 Aug 9, 2011 Alaunos Therapeutics, Inc. Director Buy 100.0 +846,522 10.58% ✗ $4M
Feb 3, 2011 Feb 7, 2011 Alaunos Therapeutics, Inc. Director Buy 100.0 +1,910,000 31.37% ✗ $11M
Jan 12, 2011 Jan 14, 2011 Alaunos Therapeutics, Inc. Director Buy 100.0 +6,088,161 250.93% ✗ $11.6M